Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Raloxifene Hydrochloride Tablets

Approval Number

国药准字H20243923

Company重庆圣华曦药业股份有限公司

Registration Date

June 4, 2024

Drug Information

Generic Name

盐酸雷洛昔芬片

Dosage Form

片剂

Strength

60mg（以 C₂₈H₂₇NO₄S·HCl 计）

Drug Type

化学药品

Registration Date

June 4, 2024

Company Information

Applicant Company

Company Name重庆圣华曦药业股份有限公司

Company Address

重庆市南岸区江桥路8号

Manufacturing Company

Company Name重庆圣华曦药业股份有限公司

Company Address

重庆市南岸区江桥路8号

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy